|
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 80.30 EUR | -0.12% |
|
+79.85% | +79.85% |
| 09:43pm | Tango Therapeutics Q2 Net Loss Widens | MT |
| 07/08 | European Equities Traded in the US as American Depositary Receipts Track Higher in Thursday Trading | MT |
| Market Cap | 20.18B 23.31B 18.86B 17.24B 32.49B 2,223B 33B 221B 86.8B 1,112B 87.53B 85.62B 3,704B | P/E 2026 * |
-14.6x | P/E 2027 * | -15.2x |
|---|---|---|---|---|---|
| Enterprise Value | 9.4B 10.86B 8.79B 8.03B 15.14B 1,036B 15.37B 103B 40.44B 518B 40.78B 39.89B 1,726B | EV / Sales 2026 * |
5.14x | EV / Sales 2027 * | 5.76x |
| Free-Float |
96.06% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: BioNTech SE
| 1 week | +0.37% | ||
| Current month | +2.42% | ||
| 1 month | +0.31% | ||
| 3 months | +0.63% | ||
| 6 months | -12.08% | ||
| Current year | -1.11% |
| 1 week | 75.7 |  | 81.55 |
| 1 month | 75.7 | | 82.3 |
| 3 years | 68.35 | | 124.7 |
| 5 years | 68.35 | | 363.9 |
| Manager | Title | Age | Since |
|---|---|---|---|
Özlem Türeci
CTO | Chief Tech/Sci/R&D Officer | 59 | 01/01/2018 |
Ugur Sahin
CEO | Chief Executive Officer | 60 | 02/06/2008 |
| Director of Finance/CFO | - | 01/07/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Helmut Jeggle
CHM | Chairman | 55 | 02/06/2008 |
| Director/Board Member | 69 | 02/06/2008 | |
| Director/Board Member | 65 | 01/01/2018 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.12% | +79.85% | -16.38% | -16.34% | 23.31B | |
| +4.21% | +25.56% | +77.96% | +104.49% | 70.85B | |
| -1.77% | +3.30% | +35.94% | +65.38% | 55.41B | |
| -1.63% | +34.32% | +17.50% | +491.37% | 29.43B | |
| -0.30% | +13.64% | +54.71% | +6.07% | 24.12B | |
| 0.00% | +1.16% | -15.42% | -13.57% | 23.31B | |
| +0.11% | +6.10% | +46.78% | -21.83% | 18.37B | |
| +7.26% | +14.16% | +221.03% | +393.89% | 16.99B | |
| 0.00% | +9.69% | +31.01% | +584.59% | 16.1B | |
| +0.08% | -4.64% | +42.74% | +148.14% | 13.12B | |
| Average | +0.87% | +391.33% | +49.59% | +174.22% | 29.75B | |
| Weighted average by Cap. | +0.98% | +350.63% | +49.08% | +146.32% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.83B 2.11B 1.71B 1.56B 2.95B 202B 2.99B 20.06B 7.87B 101B 7.94B 7.76B 336B | 1.86B 2.15B 1.74B 1.59B 3B 205B 3.05B 20.43B 8.02B 103B 8.09B 7.91B 342B |
| Net income | -1.34B -1.55B -1.25B -1.15B -2.16B -148B -2.19B -14.69B -5.77B -73.89B -5.81B -5.69B -246B | -1.34B -1.55B -1.25B -1.14B -2.16B -148B -2.19B -14.68B -5.76B -73.81B -5.81B -5.68B -246B |
| Net Debt | -10.78B -12.45B -10.08B -9.21B -17.35B -1,188B -17.62B -118B -46.36B -594B -46.75B -45.73B -1,979B | -9.44B -10.91B -8.83B -8.07B -15.2B -1,040B -15.44B -103B -40.61B -520B -40.95B -40.06B -1,733B |
| Date | Price | Change |
|---|---|---|
| 11/08/26 | EUR 80.30 | -0.12% |
| 10/08/26 | EUR 80.40 | -0.50% |
| 07/08/26 | EUR 80.80 | +1.89% |
| 06/08/26 | EUR 79.30 | -0.75% |
| 05/08/26 | EUR 79.90 | +1.33% |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- BNTX Stock
- 22UA Stock
Select your edition
All financial news and data tailored to specific country editions
